Newsroom

Press Release - Life Sciences, Diagnostics & Applied Markets

• 06 Jun 2022
  Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
• 06 Jun 2022
  Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
• 01 Jun 2022
  Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
• 27 May 2022
  Agilent Announces Collaboration with APC on Real-Time Process Monitoring
• 10 May 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
• 19 Apr 2022
  Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
• 08 Apr 2022
  Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
• 05 Apr 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
• 05 Apr 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
• 04 Apr 2022
  Agilent Joins AMBIC to Advance Biomanufacturing